Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Future Microbiology|February 18, 2015
The future for early-stage tuberculosis drug discoveryEdison S Zuniga, Julie Early, Tanya Parish
Journal of Medicinal Chemistry|February 6, 2015
Design, synthesis, and biological evaluation of theranostic vitamin-linker-taxoid conjugatesJacob G Vineberg, Tao Wang, Edison S Zuniga, et al.
Journal of Fluorine Chemistry|August 13, 2013
Fluorine-Containing Taxoid Anticancer Agents and Their Tumor-Targeted Drug DeliveryJoshua Seitz, Jacob G Vineberg, Edison S Zuniga, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2018
Activation of 2,4-Diaminoquinazoline in Mycobacterium tuberculosis by Rv3161c, a Putative DioxygenaseEduard Melief, Shilah A Bonnett, Edison S Zuniga, et al.
Future Medicinal Chemistry|December 16, 2011
Tumor-targeting drug delivery of new-generation taxoidsIwao Ojima, Edison S Zuniga, William T Berger, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2011
Targeted and armed oncolytic adenovirus via chemoselective modificationPartha S Banerjee, Edison S Zuniga, Iwao Ojima, et al.
Journal of Medicinal Chemistry|June 6, 2014
Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapyJacob G Vineberg, Edison S Zuniga, Anushree Kamath, et al.
Frontiers in Microbiology|November 13, 2018
Identification of Enolase as the Target of 2-Aminothiazoles in Mycobacterium tuberculosisHeather H Wescott, Edison S Zuniga, Anumita Bajpai, et al.
Pageof 2